Immix Biopharma, Inc.
Pharmaceutical Preparations · Los Angeles, CA, United States
- PrincipalsGabriel S MorrisCFOIlya M RachmanCEO and Chairmanand 1 more
- CompanyImmix Biopharma, Inc.Los Angeles, CA, United States
- Phone line+1 (888) 958-1084General business
Immix Biopharma, Inc. is an SEC-registered Nasdaq-listed company (ticker IMMX) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 3
Chief executive
Ilya M RachmanCEO and Chairman
Chair & board
Nancy T ChangDirector (Board)
Finance
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Ilya M Rachman — CEO and Chairman
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Gabriel S Morris — CFO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Nancy T Chang — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
InMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityIncannex Healthcare Inc.Pharmaceutical Preparations · Norwest Nsw1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capabilityKiniksa Pharmaceuticals International, plcPharmaceutical Preparations · London1 shared capabilityCannapharmarx, Inc.Pharmaceutical Preparations · Mountain View County1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilitySilence Therapeutics plcPharmaceutical Preparations · London1 shared capability